ozureprubart
GSK Acquires RAPT Therapeutics for $2.2 Billion to Advance Food Allergy Drug Ozureprubart
GSK; RAPT Therapeutics; acquisition; $2.2B; ozureprubart; food allergy; anti-IgE; immunology
Actionable Insights Powered by AI
GSK; RAPT Therapeutics; acquisition; $2.2B; ozureprubart; food allergy; anti-IgE; immunology